Imunon, Inc. (IMNN)

Arcadium Lithium Statistics

Total Valuation

Imunon has a market cap or net worth of $17.45 million. The enterprise value is $13.84 million.

Market Cap	17.45M
Enterprise Value	13.84M

Important Dates

The last earnings date was Tuesday, August 5, 2025, before market open.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Imunon has 2.52 million shares outstanding. The number of shares has increased by 62.33% in one year.

Current Share Class	2.52M
Shares Outstanding	2.52M
Shares Change (YoY)	+62.33%
Shares Change (QoQ)	+31.60%
Owned by Insiders (%)	1.34%
Owned by Institutions (%)	10.65%
Float	2.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.26
P/TBV Ratio	6.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.30, with a Debt / Equity ratio of 0.45.

Current Ratio	1.30
Quick Ratio	0.89
Debt / Equity	0.45
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -491.97% and return on invested capital (ROIC) is -222.92%.

Return on Equity (ROE)	-491.97%
Return on Assets (ROA)	-108.37%
Return on Invested Capital (ROIC)	-222.92%
Return on Capital Employed (ROCE)	-461.56%
Revenue Per Employee	n/a
Profits Per Employee	-$629,830
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.40% in the last 52 weeks. The beta is 2.16, so Imunon's price volatility has been higher than the market average.

Beta (5Y)	2.16
52-Week Price Change	-51.40%
50-Day Moving Average	11.38
200-Day Moving Average	11.63
Relative Strength Index (RSI)	41.70
Average Volume (20 Days)	489,064

Short Selling Information

The latest short interest is 297,961, so 11.82% of the outstanding shares have been sold short.

Short Interest	297,961
Short Previous Month	1.09M
Short % of Shares Out	11.82%
Short % of Float	11.98%
Short Ratio (days to cover)	0.20

Income Statement

Revenue	n/a
Gross Profit	2.72M
Operating Income	-16.02M
Pretax Income	-20.13M
Net Income	-15.75M
EBITDA	-15.78M
EBIT	-16.02M
Earnings Per Share (EPS)	-$13.47

Balance Sheet

The company has $4.73 million in cash and $1.19 million in debt, giving a net cash position of $3.54 million or $1.40 per share.

Cash & Cash Equivalents	4.73M
Total Debt	1.19M
Net Cash	3.54M
Net Cash Per Share	$1.40
Equity (Book Value)	2.66M
Book Value Per Share	1.35
Working Capital	1.57M

Cash Flow

In the last 12 months, operating cash flow was -$14.27 million and capital expenditures -$294,769, giving a free cash flow of -$14.57 million.

Operating Cash Flow	-14.27M
Capital Expenditures	-294,769
Free Cash Flow	-14.57M
FCF Per Share	-$5.78

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Imunon does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-62.33%
Shareholder Yield	-62.33%
Earnings Yield	-90.64%
FCF Yield	-83.87%

Analyst Forecast

The average price target for Imunon is $210.00, which is 2,934.68% higher than the current price. The consensus rating is "Buy".

Price Target	$210.00
Price Target Difference	2,934.68%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 7, 2025. It was a forward split with a ratio of 1.15:1.

Last Split Date	Aug 7, 2025
Split Type	Forward
Split Ratio	1.15:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1